Sunday, 1 November 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange
Price Movement Clarification

Bafna Pharmaceuticals Price Movement Clarification

Bafna Pharmaceuticals Ltd clarified to stock exchanges that recent significant share price movements are market-driven and attributable to general market conditions. The company confirmed it has not withheld any price-sensitive information and remains compliant with all SEBI disclosure regulations. Management stated they have no connection with or control over the share price movement.

Source

BSE filing, NSE: BAFNAPH. Summary written from the filing by ALFA Finder's alert engine.

Read the filing ↗

Bafna Pharmaceuticals Ltd: key numbers

Share price
₹447.90
Market cap
₹1,060 Cr
Revenue (annual)
₹150.6 Cr
Net profit (annual)
₹11.10 Cr
P/E (TTM)
136.1×Sector 45.9×
Promoter holding
75.00%+0.00% QoQ
FII holding
9.34%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

More from Bafna Pharmaceuticals Ltd

All →

Other price movement clarification announcements

All →